Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

  (Non-Clinical) Causal predictive modelling for personalised radiotherapy to reduce treatment toxicities


   Faculty of Biology, Medicine and Health

This project is no longer listed on FindAPhD.com and may not be available.

Click here to search FindAPhD.com for PhD studentship opportunities
  Dr Alan McWilliam, Dr Eliana Vasquez Osorio, Prof Corinne Faivre-Finn, Dr David Thomson, Dr Matthew Sperrin  No more applications being accepted  Competition Funded PhD Project (Students Worldwide)

About the Project

Radiotherapy uses high energy x-rays or protons to target cancer and is used as part of the treatment of >50% of cancer patients. Radiotherapy plans are unique to each patient, aiming to deliver a curative dose to the cancer while minimising dose to critical healthy tissues. It is not possible to eliminate all healthy tissue dose, which can induce toxicities that impact an individual’s quality-of-life. There is an unmet need to better understand how toxicity risk depends on the interaction of this bespoke radiotherapy dose and patient factors, to better optimise each radiotherapy plan.

Current predictive models estimate the risk of toxicity from a given 3-dimensional radiotherapy dose across each organ, accounting for patient-specific factors. However, these models only tell us the association between outcomes and predictive factors, i.e. that a patient is at risk of developing toxicities. These models cannot tell us how to change that patient’s treatment to improve their outcome, as they cannot infer what is causing the predicted risk. Causal predictive modelling is a novel statistical methodology that allows ‘what if’ queries regarding hypothetical treatments to be posed at the individual patient level.

In this project, we will focus on patients treated for lung or head and neck cancer. We will develop a novel causal predictive modelling methodology that will integrate clinical factors with the planned 3-dimensional radiotherapy dose at the image voxel level (every anatomical location). We have access to routine patient data of >1,000s of patients, with radiotherapy plan, clinical factors, and toxicity outcomes available. We also have access to a national prospective study dataset for external validation. Together, these rich data sets will allow us to investigate our hypothesis: A novel causal framework for prediction of normal tissue toxicity under hypothetical treatments can identify the optimal radiotherapy plan for every individual.

Eligibility

Candidates must hold, or be about to obtain, a minimum upper second class undergraduate degree, or the equivalent qualifications gained outside the UK, in a relevant subject. A related master's degree would be an advantage.

How to Apply

To be considered for this project you MUST submit a formal online application form. Details of how to apply are available here (https://www.bmh.manchester.ac.uk/study/research/funded-programmes/mcrc-training-scheme/apply/). For Visa requirements, international candidates must select the full-time study option.

General enquiries can be directed to [Email Address Removed].

Interviews: Friday 13 January 2023

Commencement: October 2023

Equality, Diversity and Inclusion

Equality, diversity and inclusion is fundamental to the success of The University of Manchester and is at the heart of all of our activities. The full Equality, diversity and inclusion statement can be found on the website https://www.bmh.manchester.ac.uk/study/research/apply/equality-diversity-inclusion/

Biological Sciences (4) Medicine (26)

Funding Notes

Funding will cover UK tuition fees and stipend only (currently at £21,000 per annum). The University of Manchester aims to support the most outstanding applicants from outside the UK. A limited number of scholarships will be offered to enable full studentships to be awarded to international applicants.
These full studentships for international applicants will only be awarded to exceptional quality applicants, due to the competitive nature of this scheme.
Funding is available for four years full-time, or pro rata for part-time study. Part-time awards cannot be less than 50% of full-time.